Entity
  • Alchemab Therapeutics Ltd

    Created in 2019
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    6,982
  • Activities

  • Technologies

  • Entity types

  • Location

    London N1C 4AX, UK

    London

    United Kingdom

  • Employees

    Scale: 51-200

    Estimated: 59

  • Engaged corporates

    4
    1 3
  • Added in Motherbase

    3 months, 2 weeks ago
Description
  • Value proposition

    Pioneering Patient-led Antibody Therapeutics

    Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development.
    Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies.
    Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease.

    Antibody Therapies, Immunology, and Neuro-dengeneration

Corporate interactions BETA
Corporate TypeTweets Articles
Sifted
Sifted
Newspaper Publishing
Sifted
Newspaper Publishing
Other

2 Oct 2024


Amazon Web Services (AWS)
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Amazon Web Services (AWS)
IT services, IT Services and IT Consulting
Other

30 Apr 2024


Illumina For Startups
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

28 Feb 2023


Dia & Co
Dia & Co
Semiconductors, Retail Apparel and Fashion
Dia & Co
Semiconductors, Retail Apparel and Fashion
Other

30 Apr 2024


Similar entities
Loading...
Loading...
Social network dynamics